Here at the Templeton Wellness Foundation, we’ve been covering emerging and controversial cancer research for years — long before it makes headlines. Now, according to a recent report, the U.S. National Cancer Institute is conducting preclinical studies to evaluate ivermectin’s potential ability to kill cancer cells.
Regardless of where you stand on the debate, the fact that the nation’s leading cancer research agency is taking a closer look reflects a growing willingness to investigate compounds that were once quickly dismissed. We’ll continue watching the science carefully — and reporting on it responsibly.
>>Learn more: US Cancer Institute Studying Ivermectin’s Ability To Kill Cancer Cells
